Erytech Pharma SA, a France-based oncology company that is developing treatments to starve cancer cells of nutrients, has raised €24.5 million in a share placement with qualified investors in the US and Europe. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
